Velocity Clinical Research
Velocity Clinical Research, operating over 90 sites in the U.S. and Europe, specializes in conducting clinical trials in partnership with pharmaceutical and biotechnology companies.
Company Overview
Velocity Clinical Research operates over 90 research sites across the U.S. and Europe. Founded in 1986, the company has conducted over 15,000 clinical trials. They partner with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics. Utilizing a unified research site model, they aim to deliver efficient patient care and high-quality clinical trial data.
Clinical Trial Services
Velocity Clinical Research offers extensive clinical trial services, focusing on patient recruitment and retention. Leveraging next-gen technologies and patient engagement capabilities, the company aims to enhance recruitment and retention efforts. They also emphasize diversity and community engagement in their recruitment strategies. These services ensure robust and inclusive participant pools for clinical trials.
Expert Research Team
Employing over 220 investigators, Velocity Clinical Research boasts a team with diverse experience. This team is instrumental in conducting high-quality clinical trials across various therapeutic areas. Their collective expertise enables the company to meet the stringent requirements of pharmaceutical and biotechnology partners.
Awards and Recognitions
Velocity Clinical Research has been recognized for its contributions to clinical trials. In 2023, they received Merck’s Significant Contribution to Clinical Trials Award for being a top enroller of diverse participants in cardiovascular clinical trials. Additionally, in 2024, they won the Vaccine Industry Excellence Award for Best Clinical Trial Company, highlighting their excellence in clinical trial operations.